|
Volumn 365, Issue 18, 2011, Pages 1653-1655
|
The shortage of essential chemotherapy drugs in the United States
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BLEOMYCIN;
CARBOPLATIN;
CYTARABINE;
DOCETAXEL;
DOXORUBICIN;
EPIRUBICIN;
FOLINIC ACID;
LEVOLEUCOVORIN;
METHOTREXATE;
PACLITAXEL;
VINCRISTINE;
BREAST CANCER;
CANCER MORTALITY;
CANCER PATIENT;
CHILDHOOD CANCER;
COLON CANCER;
DRUG COST;
DRUG MARKETING;
DRUG OVERDOSE;
DRUG QUALITY;
DRUG SAFETY;
DRUG SUBSTITUTION;
HEALTH CARE COST;
HUMAN;
LEUKEMIA;
LUNG CANCER;
MALIGNANT NEOPLASTIC DISEASE;
MEDICAID;
MEDICARE;
OVARY CANCER;
PRIORITY JOURNAL;
PROFIT;
REIMBURSEMENT;
SHORT SURVEY;
UNITED STATES;
|
EID: 80455144645
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMp1109772 Document Type: Short Survey |
Times cited : (106)
|
References (5)
|